派林生物(000403) - 2025 Q3 - 季度财报

Financial Performance - Revenue for Q3 2025 was CNY 631,664,756.11, a decrease of 16.23% compared to the same period last year[7] - Net profit attributable to shareholders was CNY 121,388,232.91, down 43.74% year-on-year[7] - The net profit after deducting non-recurring gains and losses was CNY 108,687,789.83, a decline of 46.09% compared to the previous year[7] - The basic earnings per share for the period was CNY 0.13, a decrease of 43.48% year-on-year[7] - Total operating revenue decreased to ¥1,618,146,526.33 from ¥1,890,265,336.27, representing a decline of approximately 14.4% year-over-year[23] - Net profit for the period was ¥357,497,339.78, down from ¥542,758,460.07, reflecting a decline of approximately 34.1% year-over-year[24] - Basic earnings per share decreased to ¥0.38 from ¥0.57, a decline of 33.3% year-over-year[25] Assets and Liabilities - Total assets at the end of the period were CNY 9,575,191,241.62, an increase of 3.56% from the end of the previous year[7] - Total current assets amount to 3,775,000,285.10 yuan, an increase from 3,578,948,533.75 yuan at the beginning of the period[19] - Total assets amount to 9,575,191,241.62 yuan, compared to 9,246,269,365.26 yuan at the beginning of the period[20] - The total liabilities increased to ¥1,556,024,436.76 from ¥1,328,766,729.91, an increase of approximately 17.0% year-over-year[22] - Total equity attributable to shareholders rose to ¥8,025,948,717.19 from ¥7,924,650,751.55, an increase of about 1.3% year-over-year[22] Cash Flow - Cash flow from operating activities was negative at CNY -96,486,845.09, a decline of 142.41% compared to the previous year[12] - The net cash flow from operating activities was -96,486,845.09, a decrease from 227,534,196.54 in the previous period, indicating a significant decline in operational performance[27] - Cash inflow from operating activities totaled ¥1,675,909,944.71, down from ¥1,898,641,784.43, a decrease of about 11.7% year-over-year[26] - Cash inflow from investment activities totaled 934,875,655.73, down from 1,004,387,646.63, reflecting a decrease in investment returns[27] - The net cash flow from investment activities was -575,403,916.88, an improvement from -841,549,214.80, suggesting reduced cash outflows in investments[27] - Cash inflow from financing activities was 534,368,741.72, compared to 366,326,135.38 in the previous period, indicating increased borrowing[27] - The net cash flow from financing activities was -75,628,923.45, slightly worse than -60,650,552.66, showing ongoing cash outflows related to financing[27] - The total cash and cash equivalents at the end of the period were 572,817,285.31, down from 753,590,120.03, indicating a decrease in liquidity[28] Inventory and Borrowings - The company reported a significant increase in inventory, which rose by 40.35% to CNY 1,730,902,371.57 due to increased production[11] - Short-term borrowings increased by 144.34% to CNY 758,641,928.53, reflecting the need for additional financing[11] - Short-term borrowings increased to 758,641,928.53 yuan from 310,489,207.30 yuan at the beginning of the period[20] - Inventory stands at 1,730,902,371.57 yuan, up from 1,233,248,553.27 yuan at the beginning of the period[19] Research and Development - Research and development expenses decreased by 32.76% to CNY 30,911,706.33, indicating a reduction in R&D activities[13] - Research and development expenses decreased to ¥30,911,706.33 from ¥45,975,375.17, a reduction of approximately 32.8% year-over-year[23] Shareholder Information - Total number of common shareholders at the end of the reporting period is 32,041[15] - The largest shareholder, Qiongqing City Shengbang Yinghao Investment Partnership, holds 21.03% of shares, totaling 199,878,656 shares, with 159,902,860 shares pledged[15] - The second-largest shareholder, Harbin Tongzhi Cheng Technology Development Co., Ltd., holds 10.99% of shares, totaling 104,495,466 shares, with 39,939,900 shares pledged[15] Other Financial Metrics - The company received government subsidies amounting to CNY 4,512,851.25 during the reporting period[9] - The company reported a decrease in investment income to ¥16,100,625.79 from ¥29,389,560.54, a decline of about 45.2% year-over-year[24] - Other comprehensive income after tax decreased to -¥6,950.72 from -¥5,639.91, indicating a worsening in comprehensive income performance[25] - The company paid 274,556,311.90 in employee-related cash outflows, an increase from 246,458,476.77, reflecting higher personnel costs[27] - The company incurred tax payments of 165,157,908.47, a decrease from 182,533,803.90, indicating a potential reduction in taxable income[27] - The cash outflow for purchasing fixed assets was 250,229,572.61, down from 295,950,586.09, suggesting a slowdown in capital expenditures[27] - The impact of exchange rate changes on cash and cash equivalents was -23,583.88, indicating minor fluctuations in currency valuation[28]